REFERENCES
  1. Centers for Medicare & Medicaid Services. Medicare-Medicaid Coordination. www.cms.gov. (Accessed January 2017)
  2. John Braithwaite. (1984). Corporate crime in the pharmaceutical industry. Routledge & Kegan Paul. London, Boston, Melbourne and Henley.
  3. FBI Website. Financial Crimes Report 2006 - Financial Crimes Report to the Public Fiscal Year 2006. www.fbi.gov
  4. Department of Health and Human Services (2010). Average Manufacturer Price and Average Sales Price Reporting Requirements. Retrieved from: https://oig.hhs.gov/fraud/docs/alertsandbulletins/2010/SpAdvBulletin_AMP_ASP.pdf
  5. The United States Department of Justice (DOJ). Fraud Statistics Overview, October 1, 1987 – September 30, 2013. www.justice.gov. (Accessed December 2016)
  6. Jim Edwards, December 7, 2010. $5B: The Cost to the Taxpayer of Drug Company Pricing Fraud. CBS News
  7. Jim Edwards, November 11, 2010. Not Dead Yet: Drug Price Manipulation Scams Enter Their Sunset Years. CBS News
  8. United States Department of Justice. November 20, 2014. Justice Department Recovers Nearly $6 Billion from False Claims Act Cases in Fiscal Year 2014. www.justice.gov
  9. United States Department of Justice. December 20, 2010. Pharmaceutical Manufacturer to Pay $280 Million to Settle False Claims Act Case. www.justice.gov
  10. Carrie Johnson, February 8, 2008. Merck to Pay $650 Million In Medicaid Settlement. Washington Post.
  11. Michael J. Sniffen. January 23, 2001. Bayer Corp. To Pay $14M Settlement. Washington Post.